Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...

Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...

While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says ...

If you’ve been debating starting a weight-loss treatment like tirzepatide or semaglutide, you’re going to want to listen ...

Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo ...

Debbie Ramos tracked her physical activity with Fitbit and used the Headspace app to meditate when stress caused comfort food ...

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional - and often ineffective - advice to "eat ...